Ovarian stimulation medications and patients' responses as prognostic factors in IUI-treated infertile Saudi patients.

Background: Intrauterine Insemination (IUI) remains the first thought of infertility treatment.

Objective: To compare the stimulation effects and Pregnancy rate (PR) outcomes of two ovulation induction (OI) medications, human-derived menopausal gonadotrophins (hMGH), Merional (MER), and recombinant follicular stimulating hormone (rFSH), Puregon (PUR), in a cohort of Saudi infertile patients, for better predictability of treatment results.

Materials And Methods: During a 24-month period, 296 women underwent IUI single treatments.